All Stories

  1. Clinical emergence of Bacteroides- associated anaerobic bacteremia due to drug-resistant non- fragilis species: a multicentric retrospective observational study

    Article • Open Forum Infectious Diseases, January 2026, Oxford University Press (OUP)

    Takahiro Takazono

  2. Clinical features of Mycobacterium abscessus complex and Mycobacterium kansasii pulmonary disease in Kyushu, Japan

    Article • Respiratory Investigation, January 2026, Elsevier

    Takahiro Takazono

  3. Efficacy of cefiderocol in murine models of ventilator-associated pneumonia caused by carbapenem-resistant non-fermenting Gram-negative bacilli, with pharmacokinetic evaluation

    Article • Microbiology Spectrum, December 2025, ASM Journals

    Takahiro Takazono, Dr. Norihito Kaku

  4. Pre-dialysis medical social worker support and survival in patients with kidney failure: impact on unplanned dialysis, hospitalization, and prognosis

    Article • Renal Failure, November 2025, Taylor & Francis

    Takahiro Takazono

  5. A case of humidifier lung potentially caused by Cryptococcus laurentii

    Article • Respiratory Investigation, November 2025, Elsevier

    Takahiro Takazono

  6. Clinical characteristics and prognosis of pulmonary aspergillosis complicating interstitial lung diseases

    Article • Respiratory Investigation, November 2025, Elsevier

    Takahiro Takazono

  7. Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis

    Article • Mycoses, October 2025, Wiley

    Takahiro Takazono

  8. Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares

    Article • Infectious Diseases and Therapy, August 2025, Springer Science + Business Media

    Takahiro Takazono

  9. Comprehensive Strategies for Prevention and Management of Antimicrobial Resistance in Respiratory Infections

    Article • Respirology, August 2025, Wiley

    Takahiro Takazono

  10. Multicentre retrospective observational study for development and validation of MAC prognostic score model

    Article • Scientific Reports, August 2025, Springer Science + Business Media

    Takahiro Takazono

  11. Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial

    Article • Viruses, July 2025, MDPI AG

    Takahiro Takazono, Dr Nobuaki Mori

  12. A nationwide epidemiological survey of coronavirus disease 2019-associated pulmonary aspergillosis in Japan

    Article • Journal of Infection and Chemotherapy, July 2025, Elsevier

    Takahiro Takazono

  13. Challenges in the diagnosis and treatment of chronic pulmonary aspergillosis in Japan

    Article • Respiratory Investigation, July 2025, Elsevier

    Takahiro Takazono

  14. Humoral and cellular immune responses to mRNA COVID-19 vaccinations in the elderly: A longitudinal study in Japan

    Article • Journal of Infection and Chemotherapy, June 2025, Elsevier

    Takahiro Takazono

  15. Incidence of Coronavirus Disease 2019‐Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review

    Article • Mycoses, June 2025, Wiley

    Takahiro Takazono

  16. Risk Factors and Long‐Term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicentre Observational Study in Japan

    Article • Mycoses, June 2025, Wiley

    Takahiro Takazono

  17. Prevotella intermedia Synergistically Exacerbates Pneumonia Induced by Oral Streptococci

    Article • The Journal of Infectious Diseases, May 2025, Oxford University Press (OUP)

    Takahiro Takazono

  18. Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan

    Article • Respiratory Investigation, May 2025, Elsevier

    Takahiro Takazono

  19. Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients

    Article • Kidney and Dialysis, April 2025, MDPI AG

    Takahiro Takazono

  20. Effects of Broad-Spectrum Antimicrobials on Patients with Community-Acquired Pneumonia with Low Risk for Drug-Resistant Pathogens: Historical Cohort Study in Japan

    Article • Infectious Diseases and Therapy, April 2025, Springer Science + Business Media

    Takahiro Takazono

  21. Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: A multisite retrospective study

    Article • International Journal of Infectious Diseases, April 2025, Elsevier

    Takahiro Takazono

  22. Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan

    Article • Antibiotics, March 2025, MDPI AG

    Takahiro Takazono

  23. TAC1b mutation in Candida auris decreases manogepix susceptibility owing to increased CDR1 expression

    Article • Antimicrobial Agents and Chemotherapy, February 2025, ASM Journals

    Takahiro Takazono

  24. Risk Factors and Long-term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicenter Observational Study in Japan

    Article • February 2025, Cold Spring Harbor Laboratory Press

    Takahiro Takazono

  25. Comprehensive Review of Environmental Surveillance for Azole-Resistant Aspergillus fumigatus: A Practical Roadmap for Hospital Clinicians and Infection Control Teams

    Article • Journal of Fungi, January 2025, MDPI AG

    Takahiro Takazono

  26. Pre-clinical and clinical evaluation of a surface plasmon field-enhanced fluorescence spectroscopy (SPFS) antigen test for detecting SARS-CoV-2

    Article • Journal of Infection and Chemotherapy, January 2025, Elsevier

    Takahiro Takazono

  27. Risk Factors and Prognostic Effects of Aspergillosis as a Complication of Nontuberculous Mycobacterial Pulmonary Disease: A Nested Case–Control Study

    Article • Mycoses, January 2025, Wiley

    Takahiro Takazono

  28. Successful granulocyte-macrophage colony-stimulating factor inhalation therapy for recurrent autoimmune pulmonary alveolar proteinosis after lung transplantation: A case report

    Article • Respiratory Investigation, January 2025, Elsevier

    Takahiro Takazono

  29. Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis

    Article • Infectious Diseases and Therapy, December 2024, Springer Science + Business Media

    Takahiro Takazono

  30. Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells

    Article • Antibiotics, September 2024, MDPI AG

    Takahiro Takazono

  31. Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B

    Article • Influenza and Other Respiratory Viruses, August 2024, Wiley

    Takahiro Takazono

  32. Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial

    Article • Journal of Infection and Chemotherapy, July 2024, Elsevier

    Takahiro Takazono

  33. Novel method of attaching a suction tube externally to a tracheal tube as an insertion route for a Fogarty catheter in cryobiopsy: Retrospective comparative study

    Article • Respiratory Investigation, July 2024, Elsevier

    Takahiro Takazono

  34. Development of a score model to predict long‐term prognosis after community‐onset pneumonia in older patients

    Article • Respirology, May 2024, Wiley

    Takahiro Takazono

  35. Risk factor of non-tuberculous Mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter retrospective study

    Article • Respiratory Investigation, May 2024, Elsevier

    Takahiro Takazono

  36. Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi

    Article • Microbiology Spectrum, April 2024, ASM Journals

    Takahiro Takazono

  37. Clinical features relating to pneumococcal colony phase variation in hospitalized adults with pneumonia

    Article • Journal of Medical Microbiology, January 2024, Society for General Microbiology

    Takahiro Takazono

  38. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges

    Article • Therapeutic Advances in Infectious Disease, January 2024, SAGE Publications

    Takahiro Takazono

  39. Prognoses of patients undergoing hemodialysis administered 23-valent pneumococcal polysaccharide versus 13-valent pneumococcal protein conjugate vaccines

    Article • Journal of Infection and Chemotherapy, December 2023, Elsevier

    Takahiro Takazono

  40. Lung Involvement in Adult T-Cell Lymphoma Diagnosed Using Bronchoscopic Cryobiopsy: A Case Report and Review of the Literature

    Article • Medicina, November 2023, MDPI AG

    Takahiro Takazono

  41. The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database

    Article • Mycoses, October 2023, Wiley

    Takahiro Takazono

  42. Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan

    Article • Medical Mycology, September 2023, Oxford University Press (OUP)

    Takahiro Takazono

  43. Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan

    Article • Open Forum Infectious Diseases, September 2023, Oxford University Press (OUP)

    Takahiro Takazono

  44. Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients

    Article • Microorganisms, August 2023, MDPI AG

    Takahiro Takazono

  45. Impact of meteorological and demographic factors on the influenza epidemic in Japan: a large observational database study

    Article • Scientific Reports, August 2023, Springer Science + Business Media

    Takahiro Takazono

  46. Evaluation of the Effectiveness and Use of Anti-Methicillin-Resistant Staphylococcus aureus Agents for Aspiration Pneumonia in Older Patients Using a Nationwide Japanese Administrative Database

    Article • Microorganisms, July 2023, MDPI AG

    Takahiro Takazono

  47. Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

    Article • Advances in Therapy, June 2023, Springer Science + Business Media

    Takahiro Takazono

  48. Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database

    Article • Viruses, May 2023, MDPI AG

    Takahiro Takazono

  49. Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System

    Article • Journal of Fungi, April 2023, MDPI AG

    Takahiro Takazono

  50. Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations

    Article • Antimicrobial Agents and Chemotherapy, April 2023, ASM Journals

    Takahiro Takazono

  51. Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan

    Article • Journal of Infection and Chemotherapy, February 2023, Elsevier

    Takahiro Takazono

  52. Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Takahiro Takazono

  53. Clinical Differentiation of Severe Fever with Thrombocytopenia Syndrome from Japanese Spotted Fever

    Article • Viruses, August 2022, MDPI AG

    Takahiro Takazono

  54. Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study

    Article • Mycoses, July 2022, Wiley

    Takahiro Takazono

  55. Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis

    Article • Journal of Fungi, April 2022, MDPI AG

    Takahiro Takazono

  56. Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis

    Article • Journal of Clinical Medicine, April 2022, MDPI AG

    Takahiro Takazono

  57. Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database

    Article • Clinical Infectious Diseases, February 2022, Oxford University Press (OUP)

    Takahiro Takazono

  58. Associations between Chest CT Abnormalities and Clinical Features in Patients with the Severe Fever with Thrombocytopenia Syndrome

    Article • Viruses, January 2022, MDPI AG

    Takahiro Takazono

  59. Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly

    Article • Journal of Infection and Chemotherapy, December 2021, Elsevier

    Takahiro Takazono

  60. Association between the psoas muscle index and hospitalization for pneumonia in patients undergoing hemodialysis

    Article • BMC Nephrology, November 2021, Springer Science + Business Media

    Takahiro Takazono

  61. The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis

    Article • Scientific Reports, November 2021, Springer Science + Business Media

    Takahiro Takazono

  62. HLA-B54 is an independent risk factor for pneumonia in Japanese patients with interstitial lung disease: A multicenter retrospective cohort study

    Article • Respiratory Medicine, November 2021, Elsevier

    Takahiro Takazono

  63. Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study

    Article • Journal of Infection and Chemotherapy, October 2021, Elsevier

    Takahiro Takazono

  64. Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: A nationwide survey by the Japanese Respiratory Society

    Article • Respiratory Investigation, October 2021, Elsevier

    Takahiro Takazono

  65. Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling

    Article • Journal of Infection and Chemotherapy, October 2021, Elsevier

    Takahiro Takazono

  66. Hemodialysis Patient with Diffuse Liver Calcification After Septic Shock

    Article • American Journal of Case Reports, September 2021, International Scientific Literature

    Takahiro Takazono

  67. Correction to: Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report

    Article • BMC Infectious Diseases, September 2021, Springer Science + Business Media

    Takahiro Takazono

  68. Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen

    Article • International Journal of Environmental Research and Public Health, September 2021, MDPI AG

    Takahiro Takazono

  69. A case of Lemierre's syndrome with double vision as the first symptom

    Article • Journal of Infection and Chemotherapy, September 2021, Elsevier

    Takahiro Takazono

  70. Assessment of oral health in elderly patients with dementia by measuring volatile sulfur compounds and its relationship with pneumonia development: A pilot study

    Article • Respiratory Investigation, September 2021, Elsevier

    Takahiro Takazono

  71. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society

    Article • ERJ Open Research, August 2021, European Respiratory Society (ERS)

    Takahiro Takazono

  72. Infectious Pneumonia and Lower Airway Microorganisms in Patients with Rheumatoid Arthritis

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Takahiro Takazono

  73. Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests

    Article • Journal of Infection and Chemotherapy, July 2021, Elsevier

    Takahiro Takazono

  74. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study

    Article • BMC Nephrology, June 2021, Springer Science + Business Media

    Takahiro Takazono

  75. Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report

    Article • BMC Infectious Diseases, June 2021, Springer Science + Business Media

    Takahiro Takazono

  76. Pneumonia in patients with rheumatoid arthritis: effect of microbial airway colonization

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Takahiro Takazono

  77. Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance

    Article • Journal of Infection and Chemotherapy, March 2021, Elsevier

    Takahiro Takazono

  78. Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis

    Article • Journal of Infection and Chemotherapy, March 2021, Elsevier

    Takahiro Takazono

  79. Effects of surgical masks on droplet dispersion under various oxygen delivery modalities

    Article • Critical Care, February 2021, Springer Science + Business Media

    Takahiro Takazono

  80. COVID-19 cryptic transmission and genetic information blackouts: Need for effective surveillance policy to better understand disease burden

    Article • The Lancet Regional Health - Western Pacific, February 2021, Elsevier

    Takahiro Takazono

  81. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report

    Article • International Journal of Infectious Diseases, February 2021, Elsevier

    Takahiro Takazono

  82. Effects of surgical masks on droplet and aerosol dispersion under various oxygen delivery modalities

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Takahiro Takazono

  83. Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study

    Article • Clinical and Experimental Nephrology, January 2021, Springer Science + Business Media

    Takahiro Takazono

  84. Reply to Shirata et al

    Article • Clinical Infectious Diseases, January 2021, Oxford University Press (OUP)

    Takahiro Takazono

  85. Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis

    Article • Journal of Medical Economics, January 2021, Taylor & Francis

    Takahiro Takazono

  86. ERG3-Encoding Sterol C5,6-DESATURASE in Candida albicans Is Required for Virulence in an Enterically Infected Invasive Candidiasis Mouse Model

    Article • Pathogens, December 2020, MDPI AG

    Takahiro Takazono

  87. Diagnostic evaluation of serum (1, 3)-β-d-glucan levels using the Fungitec G-Test MK kit for Pneumocystis jirovecii pneumonia (PCP) in non-HIV patients

    Article • Medical Mycology, December 2020, Oxford University Press (OUP)

    Takahiro Takazono

  88. Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study

    Article • Clinical Infectious Diseases, December 2020, Oxford University Press (OUP)

    Takahiro Takazono

  89. Duration of antifungal therapy for septic pulmonary embolism caused by Candida albicans from a central venous catheter: A case report

    Article • Clinical Case Reports, December 2020, Wiley

    Takahiro Takazono

  90. The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study

    Article • Clinical and Experimental Nephrology, November 2020, Springer Science + Business Media

    Takahiro Takazono

  91. Discrepancies in preferences regarding the care of terminal-phase pneumonia in elderly patients among patients, families, and doctors: A multicenter questionnaire survey in nagasaki, Japan

    Article • Respiratory Investigation, November 2020, Elsevier

    Takahiro Takazono

  92. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study

    Article • Clinical Infectious Diseases, October 2020, Oxford University Press (OUP)

    Takahiro Takazono

  93. Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Takeshi Ishikawa, Takahiro Takazono

  94. Characteristics of azole-resistant Aspergillus fumigatus attached to agricultural products imported to Japan

    Article • Journal of Infection and Chemotherapy, October 2020, Elsevier

    Takahiro Takazono

  95. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan

    Article • Scientific Reports, September 2020, Springer Science + Business Media

    Takahiro Takazono

  96. Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection

    Article • PLoS Pathogens, August 2020, PLOS

    Takahiro Takazono

  97. Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report

    Article • AIDS Research and Therapy, July 2020, Springer Science + Business Media

    Takahiro Takazono

  98. Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata

    Article • Scientific Reports, June 2020, Springer Science + Business Media

    Takahiro Takazono

  99. Evaluation of endobronchial volatile sulfur compounds for rapid diagnosis of lung abscesses caused by obligate anaerobes using Oral Chroma™: A pilot study

    Article • Respiratory Investigation, May 2020, Elsevier

    Takahiro Takazono

  100. Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review

    Article • BMC Infectious Diseases, April 2020, Springer Science + Business Media

    Takahiro Takazono

  101. Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation

    Article • Scientific Reports, March 2020, Springer Science + Business Media

    Takahiro Takazono

  102. Design and Synthesis of a Class of Compounds That Inhibit the Growth of Fungi Which Cause Invasive Infections

    Article • ChemistrySelect, January 2020, Wiley

    Takahiro Takazono

  103. Detection of invasive pulmonary aspergillosis in mice using lung perfusion single-photon emission computed tomography with [99mTc]MAA

    Article • Medical Mycology, January 2020, Oxford University Press (OUP)

    Takahiro Takazono

  104. An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination

    Article • Emerging Microbes & Infections, January 2020, Taylor & Francis

    Takahiro Takazono

  105. Executive Summary of JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Cryptococcosis 2019

    Article • Medical Mycology Journal, January 2020, The Japanese Society for Medical Mycology

    Takahiro Takazono

  106. Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan

    Article • Emerging Infectious Diseases, November 2019, Centers for Disease Control and Prevention (CDC)

    Takahiro Takazono

  107. The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial

    Article • Journal of Infection and Chemotherapy, November 2019, Elsevier

    Takahiro Takazono

  108. Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitive element sequence-based polymerase chain reaction: a case report

    Article • Journal of Medical Case Reports, September 2019, Springer Science + Business Media

    Takahiro Takazono

  109. Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study

    Article • Journal of Infection and Chemotherapy, September 2019, Elsevier

    Dr. Norihito Kaku, Takahiro Takazono

  110. Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis

    Article • Scientific Reports, June 2019, Springer Science + Business Media

    Takahiro Takazono

  111. Evaluation of Aspergillus -Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis

    Article • Journal of Clinical Microbiology, May 2019, ASM Journals

    Takahiro Takazono

  112. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis

    Article • Clinical Infectious Diseases, April 2019, Oxford University Press (OUP)

    Takahiro Takazono

  113. A case of bilateral emphysematous pyelonephritis caused by Candida albicans

    Article • Journal of Infection and Chemotherapy, April 2019, Elsevier

    Takahiro Takazono

  114. Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2019, Springer Science + Business Media

    Takahiro Takazono

  115. Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata

    Article • Frontiers in Microbiology, January 2019, Frontiers

    Takahiro Takazono

  116. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata

    Article • PLOS One, January 2019, PLOS

    Takahiro Takazono

  117. Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis

    Article • Frontiers in Microbiology, August 2018, Frontiers

    Takahiro Takazono

  118. Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Takahiro Takazono

  119. Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia

    Article • BMC Pulmonary Medicine, December 2017, Springer Science + Business Media

    Takahiro Takazono

  120. A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels

    Article • Journal of Infection and Chemotherapy, September 2017, Elsevier

    Takahiro Takazono

  121. Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study

    Article • Clinical Infectious Diseases, August 2017, Oxford University Press (OUP)

    Takahiro Takazono

  122. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species

    Article • PLOS One, July 2017, PLOS

    Takahiro Takazono

  123. Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients

    Article • Medical Mycology, April 2017, Oxford University Press (OUP)

    Takahiro Takazono

  124. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

    Article • Journal of Antimicrobial Chemotherapy, February 2017, Oxford University Press (OUP)

    Takahiro Takazono

  125. Aspergillusin chronic lung disease: Modeling what goes on in the airways

    Article • Medical Mycology, November 2016, Oxford University Press (OUP)

    Takahiro Takazono

  126. Roles of vacuolar H+-ATPase in the oxidative stress response ofCandida glabrata

    Article • FEMS Yeast Research, July 2016, Oxford University Press (OUP)

    Takahiro Takazono

  127. The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan

    Article • Journal of Infection and Chemotherapy, July 2016, Elsevier

    Takahiro Takazono

  128. A mortality prediction rule for non-elderly patients with community-acquired pneumonia

    Article • BMC Pulmonary Medicine, March 2016, Springer Science + Business Media

    Takahiro Takazono

  129. An Autopsy Case of Lepidic Pulmonary Metastasis from Cholangiocarcinoma

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Takahiro Takazono

  130. Pulmonary Nocardiosis Caused by Nocardia concava with a Literature Review

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Takahiro Takazono

  131. Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Takahiro Takazono

  132. Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Takahiro Takazono

  133. Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Takahiro Takazono

  134. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria

    Article • Medical Mycology, November 2015, Oxford University Press (OUP)

    Takahiro Takazono

  135. Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study

    Article • BMC Infectious Diseases, October 2015, Springer Science + Business Media

    Takahiro Takazono

  136. Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice

    Article • The Journal of Infectious Diseases, March 2015, Oxford University Press (OUP)

    Takahiro Takazono

  137. Contribution of the Slt2-regulated transcription factors to echinocandin tolerance inCandida glabrata

    Article • FEMS Yeast Research, September 2014, Oxford University Press (OUP)

    Takahiro Takazono

  138. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients

    Article • Journal of Infection and Chemotherapy, August 2014, Elsevier

    Takahiro Takazono

  139. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literature

    Article • Journal of Infection and Chemotherapy, March 2014, Elsevier

    Takahiro Takazono

  140. Pathogenesis and clinical features of chronic pulmonary aspergillosis – Is it possible to distinguish CNPA and CCPA clinically?

    Article • Journal of Infection and Chemotherapy, March 2014, Elsevier

    Takahiro Takazono

  141. Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report

    Article • BMC Infectious Diseases, February 2014, Springer Science + Business Media

    Takahiro Takazono

  142. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis

    Article • Journal of Infection and Chemotherapy, February 2014, Elsevier

    Takahiro Takazono

  143. A Fatal Case of Acute Myocardial Infarction following the Improvement of Influenza A(H1N1)pdm2009-related Acute Myocarditis

    Article • Internal Medicine, January 2014, Japanese Society of Internal Medicine

    Takahiro Takazono

  144. Concurrent Subcutaneous Candidal Abscesses and Pulmonary Cryptococcosis in a Patient with Diabetes Mellitus and a History of Corticosteroid Therapy

    Article • Internal Medicine, January 2014, Japanese Society of Internal Medicine

    Takahiro Takazono

  145. Importance of Functional Assessment in the Management of Community-acquired and Healthcare-associated Pneumonia

    Article • Internal Medicine, January 2014, Japanese Society of Internal Medicine

    Takahiro Takazono

  146. Three Cases of Concurrent Infection with Mycobacterium tuberculosis and Cryptococcus neoformans

    Article • Internal Medicine, January 2014, Japanese Society of Internal Medicine

    Takahiro Takazono

  147. Two Cases of Emphysematous Urinary Tract Infections Successfully Treated with Conservative Management

    Article • Kansenshogaku zasshi, January 2014, The Japanese Association for Infectious Diseases

    Takahiro Takazono

  148. Multilocus sequence typing ofCryptococcus neoformansin non-HIV associated cryptococcosis in Nagasaki, Japan

    Article • Medical Mycology, April 2013, Oxford University Press (OUP)

    Takahiro Takazono

  149. Cavitary Pulmonary Metastases and Aspergillosis: An Autopsy Case

    Article • Internal Medicine, January 2013, Japanese Society of Internal Medicine

    Takahiro Takazono

  150. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis

    Article • Medical Mycology, November 2012, Oxford University Press (OUP)

    Takahiro Takazono

  151. A case of bronchial aspergillosis caused byAspergillus udagawaeand its mycological features

    Article • Medical Mycology, August 2012, Oxford University Press (OUP)

    Takahiro Takazono

  152. Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus

    Article • Antimicrobial Agents and Chemotherapy, July 2012, ASM Journals

    Takahiro Takazono

  153. A 44-Year-Old Japanese Female with Recurrent Pleuritis

    Article • Respiration, January 2012, Karger Publishers

    Takahiro Takazono

  154. Possible Pulmonary Cryptococcosis in a Patient with Crohn's Disease during Anti-Tumor Necrosis Factor-Alpha Treatment: a Case Report and Literature Review

    Article • Japanese Journal of Infectious Diseases, January 2012, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Takahiro Takazono

  155. Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan

    Article • Antimicrobial Agents and Chemotherapy, October 2011, ASM Journals

    Takahiro Takazono

  156. Diagnostic significance ofAspergillusspecies isolated from respiratory samples in an adult pneumology ward

    Article • Medical Mycology, January 2011, Oxford University Press (OUP)

    Takahiro Takazono

  157. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance

    Article • Current Opinion in Infectious Diseases, December 2010, Wolters Kluwer Health

    Takahiro Takazono

  158. Skn7p Is Involved in Oxidative Stress Response and Virulence of Candida glabrata

    Article • Mycopathologia, August 2009, Springer Science + Business Media

    Takahiro Takazono

  159. Efficacy of Combination Antifungal Therapy with Intraperitoneally Administered Micafungin and Aerosolized Liposomal Amphotericin B against Murine Invasive Pulmonary Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, June 2009, ASM Journals

    Takahiro Takazono

  160. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment

    Article • Medical Mycology, January 2008, Oxford University Press (OUP)

    Takahiro Takazono

  161. An Autopsy Case of Erysipelothrix Rhusiopathiae Endocarditis

    Article • Internal Medicine, January 2008, Japanese Society of Internal Medicine

    Takahiro Takazono

  162. Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis Successfully Treated with Polymyxin B-immobilized Fiber Column Hemoperfusion

    Article • Internal Medicine, January 2008, Japanese Society of Internal Medicine

    Takahiro Takazono